Item 5. Market for Registrant’s Common Equity
ITEM
5 - MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Market
Information
Our
common stock is listed on the NYSE American LLC Exchange, where it trades under the symbol “DSS”.
Holders
of Record
As
of March 24, 2025, we had 311 record holders of our common stock. This number does not include the number of persons whose shares
are in nominee or in “street name” accounts through brokers.
Dividends
We
did not pay dividends during 2024. In 2023, we did not pay cash dividends. In April 2023, DSS distributed to its shareholders two (2)
shares of its beneficially owned common stock of Sharing Services Global Corporation (OTC: SHRG) for each share of DSS common stock owned.
In August of 2023, the Company issued four (4) shares of Impact BioMedical, Inc., formerly a wholly-owned subsidiary of the Company,
to its shareholders of record on July 10, 2023.
The
payment of dividends on our common stock is subject to the discretion of our board of directors and will depend on our operations, financial
position, financial requirements, general business conditions, restrictions imposed by financing arrangements, if any, legal restrictions
on the payment of dividends and other factors that our board of directors deems relevant.
Securities
Authorized for Issuance Under Equity Compensation Plans
As
of December 31, 2024, securities issued and securities available for future issuance under both our 2013 and 2020 Employee, Director
and Consultant Equity Incentive Plan (the “Plans”) is as follows:
Restricted stock to be issued upon vesting
Number of securities to be issued upon exercise of outstanding options, warrants and rights
Weighted average exercise price of outstanding options, warrants and rights
Number of securities
remaining available for
future issuance (under equity compensation
Plans (excluding
securities reflected in
column (a & b))
Plan Category
(a)
(b)
(c)
(d)
Equity compensation plans approved by security holders
2013 Employee, Director and Consultant Equity Incentive Plan - options
-
-
$ -
-
2013 Employee, Director and Consultant Equity Incentive Plan - warrants
-
-
$ -
-
2020 Employee, Director and Consultant Equity Incentive Plan
-
-
$ -
814,184
Total
-
-
$ -
814,184
Recent
Issuances of Unregistered Securities
Information
regarding any equity securities we have sold during the period covered by this Report that were not registered under the Securities Act
of 1933, as amended, and was not included in a quarterly report on Form 10-Q or in a current report on Form 8-K, is set forth below.
Each such transaction was exempt from the registration requirements of the Securities Act by virtue of Section 4(a)(2) of the Securities
Act or Rule 506 of Regulation D promulgated by the SEC, unless otherwise noted. Unless stated otherwise: (i) the securities were offered
and sold only to accredited investors; (ii) there was no general solicitation or general advertising related to the offerings; (iii)
each of the persons who received these unregistered securities had knowledge and experience in financial and business matters which allowed
them to evaluate the merits and risk of the receipt of these securities, and that they were knowledgeable about our operations and financial
condition; (iv) no underwriter participated in, nor did we pay any commissions or fees to any underwriter in connection with the transactions;
and, (v) each certificate issued for these unregistered securities contained a legend stating that the securities have not been registered
under the Securities Act and setting forth the restrictions on the transferability and the sale of the securities.
Shares
Repurchased by the Registrant
We
did not purchase or repurchase any of our securities in the fiscal year ended December 31, 2024.
ITEM
6 - SELECTED FINANCIAL DATA
Not
applicable.
22